Literature DB >> 25552700

Chronic lymphocytic leukemia cells in lymph nodes show frequent NOTCH1 activation.

Arantza Onaindia1, Sagrario Gómez2, Miguel Piris-Villaespesa3, Carolina Martínez-Laperche4, Laura Cereceda1, Santiago Montes-Moreno1, Ana Batlle1, Sonia González de Villambrosia1, Marina Pollán5, Paloma Martín-Acosta6, Julia González-Rincón2, Javier Menarguez4, Javier Alvés7, Socorro M Rodriguez-Pinilla8, Juan F García9, Manuela Mollejo10, Máximo Fraga11, José A García-Marco3, Miguel A Piris1, Margarita Sánchez-Beato12.   

Abstract

Entities:  

Keywords:  NOTCH1 activation; chronic lymphocytic leukemia

Mesh：

Substances：

Year:  2014        PMID： 25552700      PMCID： PMC4420232          DOI： 10.3324/haematol.2014.117705

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia.

Authors:  Davide Rossi; Silvia Rasi; Giulia Fabbri; Valeria Spina; Marco Fangazio; Francesco Forconi; Roberto Marasca; Luca Laurenti; Alessio Bruscaggin; Michaela Cerri; Sara Monti; Stefania Cresta; Rosella Famà; Lorenzo De Paoli; Pietro Bulian; Valter Gattei; Anna Guarini; Silvia Deaglio; Daniela Capello; Raul Rabadan; Laura Pasqualucci; Riccardo Dalla-Favera; Robin Foà; Gianluca Gaidano
Journal:  Blood       Date:  2011-11-10       Impact factor: 22.113

2.  Functional impact of NOTCH1 mutations in chronic lymphocytic leukemia.

Authors:  F Arruga; B Gizdic; S Serra; T Vaisitti; C Ciardullo; M Coscia; L Laurenti; G D'Arena; O Jaksic; G Inghirami; D Rossi; G Gaidano; S Deaglio
Journal:  Leukemia       Date:  2013-10-30       Impact factor: 11.528

3.  SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1, FBXW7, MYD88, XPO1 and TP53 in 1160 untreated CLL patients.

Authors:  S Jeromin; S Weissmann; C Haferlach; F Dicker; K Bayer; V Grossmann; T Alpermann; A Roller; A Kohlmann; T Haferlach; W Kern; S Schnittger
Journal:  Leukemia       Date:  2013-09-12       Impact factor: 11.528

Review 4.  Next-generation sequencing in chronic lymphocytic leukemia.

Authors:  Neus Villamor; Armando López-Guillermo; Carlos López-Otín; Elías Campo
Journal:  Semin Hematol       Date:  2013-10       Impact factor: 3.851

5.  Proliferation centers in chronic lymphocytic leukemia: the niche where NF-kappaB activation takes place.

Authors:  B Herreros; S M Rodríguez-Pinilla; R Pajares; M A Martínez-Gónzalez; R Ramos; I Munoz; S Montes-Moreno; M Lozano; L Sánchez-Verde; G Roncador; M Sánchez-Beato; R D de Otazu; M Pérez-Guillermo; M J Mestre; C Bellas; M A Piris
Journal:  Leukemia       Date:  2010-01-14       Impact factor: 11.528

6.  Targeting the NF-kappaB signaling pathway in Notch1-induced T-cell leukemia.

Authors:  Tomas Vilimas; Joaquina Mascarenhas; Teresa Palomero; Malay Mandal; Silvia Buonamici; Fanyong Meng; Benjamín Thompson; Christina Spaulding; Sami Macaroun; Maria-Luisa Alegre; Barbara L Kee; Adolfo Ferrando; Lucio Miele; Iannis Aifantis
Journal:  Nat Med       Date:  2006-12-17       Impact factor: 53.440

7.  The γ-secretase inhibitor PF-03084014 combined with fludarabine antagonizes migration, invasion and angiogenesis in NOTCH1-mutated CLL cells.

Authors:  M López-Guerra; S Xargay-Torrent; L Rosich; A Montraveta; J Roldán; A Matas-Céspedes; N Villamor; M Aymerich; C López-Otín; P Pérez-Galán; G Roué; E Campo; D Colomer
Journal:  Leukemia       Date:  2014-04-30       Impact factor: 11.528

8.  NOTCH1, SF3B1, and TP53 mutations in fludarabine-refractory CLL patients treated with alemtuzumab: results from the CLL2H trial of the GCLLSG.

Authors:  Andrea Schnaiter; Peter Paschka; Marianna Rossi; Thorsten Zenz; Andreas Bühler; Dirk Winkler; Mario Cazzola; Konstanze Döhner; Jennifer Edelmann; Daniel Mertens; Sabrina Kless; Silja Mack; Raymonde Busch; Michael Hallek; Hartmut Döhner; Stephan Stilgenbauer
Journal:  Blood       Date:  2013-07-02       Impact factor: 22.113

9.  Gauging NOTCH1 Activation in Cancer Using Immunohistochemistry.

Authors:  Michael J Kluk; Todd Ashworth; Hongfang Wang; Birgit Knoechel; Emily F Mason; Elizabeth A Morgan; David Dorfman; Geraldine Pinkus; Oliver Weigert; Jason L Hornick; Lucian R Chirieac; Michelle Hirsch; David J Oh; Andrew P South; Irene M Leigh; Celine Pourreyron; Andrew J Cassidy; Daniel J Deangelo; David M Weinstock; Ian E Krop; Deborah Dillon; Jane E Brock; Alexander J F Lazar; Myron Peto; Raymond J Cho; Alexander Stoeck; Brian B Haines; Sriram Sathayanrayanan; Scott Rodig; Jon C Aster
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

10.  Hes repressors are essential regulators of hematopoietic stem cell development downstream of Notch signaling.

Authors:  Jordi Guiu; Ritsuko Shimizu; Teresa D'Altri; Stuart T Fraser; Jun Hatakeyama; Emery H Bresnick; Ryoichiro Kageyama; Elaine Dzierzak; Masayuki Yamamoto; Lluis Espinosa; Anna Bigas
Journal:  J Exp Med       Date:  2012-12-24       Impact factor: 14.307
View more
  7 in total

1.  Common nonmutational NOTCH1 activation in chronic lymphocytic leukemia.

Authors:  Giulia Fabbri; Antony B Holmes; Mara Viganotti; Claudio Scuoppo; Laura Belver; Daniel Herranz; Xiao-Jie Yan; Yasmine Kieso; Davide Rossi; Gianluca Gaidano; Nicholas Chiorazzi; Adolfo A Ferrando; Riccardo Dalla-Favera
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-17       Impact factor: 11.205

2.  The morphology of CLL revisited: the clinical significance of prolymphocytes and correlations with prognostic/molecular markers in the LRF CLL4 trial.

Authors:  David Oscier; Monica Else; Estella Matutes; Ricardo Morilla; Jonathan C Strefford; Daniel Catovsky
Journal:  Br J Haematol       Date:  2016-05-06       Impact factor: 6.998

Review 3.  Chemotactic Cues for NOTCH1-Dependent Leukemia.

Authors:  Erich Piovan; Valeria Tosello; Alberto Amadori; Paola Zanovello
Journal:  Front Immunol       Date:  2018-04-03       Impact factor: 7.561

4.  IL-4-dependent Jagged1 expression/processing is associated with survival of chronic lymphocytic leukemia cells but not with Notch activation.

Authors:  Filomena De Falco; Beatrice Del Papa; Stefano Baldoni; Rita Sabatini; Franca Falzetti; Mauro Di Ianni; Maria Paola Martelli; Federica Mezzasoma; Maria Pelullo; Pierfrancesco Marconi; Paolo Sportoletti; Isabella Screpanti; Emanuela Rosati
Journal:  Cell Death Dis       Date:  2018-11-26       Impact factor: 8.469

Review 5.  The NOTCH Pathway and Its Mutations in Mature B Cell Malignancies.

Authors:  Francesca Arruga; Tiziana Vaisitti; Silvia Deaglio
Journal:  Front Oncol       Date:  2018-11-26       Impact factor: 6.244

Review 6.  Multiple Mechanisms of NOTCH1 Activation in Chronic Lymphocytic Leukemia: NOTCH1 Mutations and Beyond.

Authors:  Federico Pozzo; Tamara Bittolo; Erika Tissino; Antonella Zucchetto; Riccardo Bomben; Laura Polcik; Svenja Dannewitz Prosseda; Tanja Nicole Hartmann; Valter Gattei
Journal:  Cancers (Basel)       Date:  2022-06-17       Impact factor: 6.575

Review 7.  NOTCH1 Aberrations in Chronic Lymphocytic Leukemia.

Authors:  Emanuela Rosati; Stefano Baldoni; Filomena De Falco; Beatrice Del Papa; Erica Dorillo; Chiara Rompietti; Elisa Albi; Franca Falzetti; Mauro Di Ianni; Paolo Sportoletti
Journal:  Front Oncol       Date:  2018-06-27       Impact factor: 6.244
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.